A detailed history of Quantbot Technologies LP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 20,500 shares of AUPH stock, worth $111,315. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,500
Holding current value
$111,315
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$4.93 - $9.31 $101,065 - $190,855
20,500 New
20,500 $102,000
Q3 2022

Nov 07, 2022

BUY
$6.66 - $12.39 $197,136 - $366,744
29,600 New
29,600 $222,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $770M
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.